Back

Watch Compare

ONCOLYTICS BIOTECH INC

Data quality: 83%

ONCY

NASDAQ Manufacturing Chemicals

$1.06

▼ $0.04 (-3.64%)

6 months return

—

Momentum

Neutral

Free cash flow

-20.12 M

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROIC-1532.26%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio1.12

Interest CoverageN/A

Valuation

PE (TTM|NTM)

-4.12 | -2.99

Below sector avg (-1.50)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -20.12 M

Price History

Financial Trends

Analyst Price Target

6 analysts

Buy

+384.2%

upside to target

Current

$1.06

Consensus Target

$5.13

$2.95

Low

$10.07

High

Forecast

Forward P/E

-2.99

Forward EPS

-$0.37

Est. Revenue

0.0

Earnings Surprises

EPS

Reported Estimate Forecast

Next: Q1 2026 · EPS Est: -$0.07 · Rev Est: 0.0

	Q12025	Q22025	Q32025	Q42025	Q1 '26	Q2 '26
Reported	-$0.08	-$0.07	-$0.14	—	—	—
Estimate	-$0.09	-$0.08	-$0.07	-$0.09	-$0.07	-$0.08
Surprise	+11.11%	+17.33%	-108.18%	—	—	—

Growth

Rev 5Y: N/A · Earnings 1Y: N/A

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: N/A · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	-28.76 M
ROE	N/A	ROA	-379.31%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-20.12 M
ROIC	-1532.26%	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: 1.12

Debt / Equity	N/A	Current Ratio	1.12
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	743,000	Tangible Book Value	-3.80 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -4.12 · EV/EBITDA: N/A

P/E Ratio	-4.12	Forward P/E	-2.99
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-16.98%
Market Cap	118.45 M	Enterprise Value	113.25 M

Per Share

EPS: -0.30 · FCF/Share: -0.17

EPS (Diluted TTM)	-0.30	Revenue / Share	N/A
FCF / Share	-0.17	OCF / Share	-0.17
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 69.95% · CapEx/Rev: N/A

CapEx / Revenue	N/A	FCF Conversion	69.95%
SBC-Adj. FCF	-23.22 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025
Revenue	—
Net Income	-28.76 M
EPS (Diluted)	-0.30
Gross Profit	—
Operating Income	-28.73 M
EBITDA	—
R&D Expenses	13.31 M
SG&A Expenses	—
D&A	—
Interest Expense	—
Income Tax	79,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025
Total Assets	7.58 M
Total Liabilities	11.38 M
Shareholders' Equity	-3.80 M
Total Debt	—
Cash & Equivalents	5.20 M
Current Assets	6.84 M
Current Liabilities	6.10 M

Peer Comparison

vs Manufacturing sector median (1605 peers)

Metric	Stock	Sector Median
P/E	-4.1	-1.5
P/B	—	1.6
ROE %	—	-54.5
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3